Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Aug 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The CHoBI7 trial is studying a new way to reduce cholera infections and promote better water, sanitation, and hygiene (WASH) practices in areas where cholera is common. The goal is to help families affected by cholera by improving their access to clean water and sanitation facilities. The researchers are specifically looking at neighborhoods around cholera cases to see if this targeted approach can make a difference in preventing the disease and encouraging lasting good hygiene habits.
To participate in the trial, you need to have a household member who has cholera and does not have running water in their home. Importantly, anyone can join the study, regardless of age, gender, religion, or sexual preference. If you choose to take part, you can expect to receive support and resources to help improve your home’s water and sanitation conditions. The trial is currently recruiting participants, and everyone involved will be contributing to important research that could help many families in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Index cholera patient have no running water inside of their home
- Exclusion Criteria:
- • No one will be excluded because of age, sex, religion, or sexual preference
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dhaka, , Bangladesh
Dhaka, , Bangladesh
Patients applied
Trial Officials
Christine Marie George, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported